[Treatment of chronic myelogenous leukemia with oral bis (3-mesyloxypropyl) amine p-toluenesulfonate].
D000284:Administration, Oral; D000328:Adult; D000476:Alkanesulfonates / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D000477:Alkylating Agents / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D014105:Tosyl Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use
D000476:Alkanesulfonates; D000477:Alkylating Agents; D014105:Tosyl Compounds